Karyopharm Therapeutics Inc. (KPTI) Social Stream
KARYOPHARM THERAPEUTICS INC (KPTI) Price Targets From Analysts
Use the tables below to see what analysts covering KARYOPHARM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $35 | $6 | $17.714 | $5.63 | 214.64% |
| 2021-11-19 | 8 | $35 | $6 | $15.285 | $5.63 | 171.49% |
| 2021-12-21 | 8 | $35 | $6 | $15.571 | $5.63 | 176.57% |
| 2022-02-01 | 8 | $35 | $8 | $16 | $5.63 | 184.19% |
| 2022-02-09 | 8 | $35 | $8 | $16.428 | $5.63 | 191.79% |
| 2022-03-02 | 8 | $35 | $8 | $14.875 | $5.63 | 164.21% |
| 2022-03-18 | 8 | $35 | $6 | $14.625 | $5.63 | 159.77% |
| 2022-04-12 | 7 | $22 | $6 | $11.714 | $5.63 | 108.06% |
| 2022-05-06 | 7 | $22 | $6 | $11.5 | $5.63 | 104.26% |
| 2022-07-14 | 7 | $21 | $5 | $10.875 | $5.63 | 93.16% |
| 2022-08-04 | 9 | $18 | $5 | $10.5 | $5.63 | 86.5% |
| 2022-08-05 | 8 | $18 | $5 | $10.1 | $5.63 | 79.4% |
| 2022-10-20 | 8 | $18 | $5 | $9.8 | $5.63 | 74.07% |
| 2022-11-04 | 9 | $18 | $5 | $9.9 | $5.63 | 75.84% |
The Trend in the Analyst Price Target
Over the past 20 months, KPTI's average price target has gone down $20.3.
Over the past 50 weeks, KPTI's average upside potential has been 98.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 8 | 35 | 6 | 15.285 | 7.57 | 101.92% |
| 2022-03-18 | 8 | 35 | 6 | 14.625 | 7.18 | 103.69% |
| 2022-04-12 | 7 | 22 | 6 | 11.714 | 7.57 | 54.74% |
| 2022-05-27 | 7 | 21 | 5 | 10.875 | 6.38 | 70.45% |
| 2022-11-04 | 9 | 18 | 5 | 9.700 | 4.74 | 104.64% |
KPTI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 4 | 1 | 4 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 35 weeks, KPTI's average broker recommendation rating improved by 0.25.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KPTI as an investment opportunity.
- In the context of all US stocks, KARYOPHARM THERAPEUTICS INC's variance in analysts' estimates is lower than -1722.09% of them.
- KPTI has a greater number of analysts covering the stock than 1753.64% of stocks in the small market cap category.
- KARYOPHARM THERAPEUTICS INC's average analyst price target is greater than 443.37% of Healthcare stocks.
- In terms of how KARYOPHARM THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 795.32% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KARYOPHARM THERAPEUTICS INC are TVTX, FBIO, and ASMB.
View All Top Stocks by Price Target
Is KPTI a Buy, Hold or Sell? See the POWR Ratings now!